A Rare Case of Anti-Mi-2 Antibody-Positive Dermatomyositis Associated With Gastrointestinal Stromal Tumor

Dermatomyositis (DM) with myositis-specific autoantibodies (MSAs) such as anti-Mi-2 antibody confers a negative risk for malignancy. A diagnosis of DM carries a 24% risk of developing a malignancy. .

Saved in:
Bibliographic Details
Published inJournal of rheumatology
Main Authors Akpoigbe, Okeoghene, Anim-Koranteng, Comfort, Tasmin, Ruhina, Sammut, Amanda
Format Journal Article
LanguageEnglish
Published Canada 01.09.2024
Online AccessGet more information

Cover

More Information
Summary:Dermatomyositis (DM) with myositis-specific autoantibodies (MSAs) such as anti-Mi-2 antibody confers a negative risk for malignancy. A diagnosis of DM carries a 24% risk of developing a malignancy. .
ISSN:1499-2752
DOI:10.3899/jrheum.2024-0114